145 related articles for article (PubMed ID: 29909202)
1. Methylation changes and aberrant expression of FGFR3 in Lewy body disease neurons.
Tsuchida T; Mano T; Koshi-Mano K; Bannai T; Matsubara T; Yamashita S; Ushijima T; Nagata K; Murayama S; Toda T; Tsuji S; Iwata A
Brain Res; 2018 Oct; 1697():59-66. PubMed ID: 29909202
[TBL] [Abstract][Full Text] [Related]
2. Regional Overlap of Pathologies in Lewy Body Disorders.
Colom-Cadena M; Grau-Rivera O; Planellas L; Cerquera C; Morenas E; Helgueta S; Muñoz L; Kulisevsky J; Martí MJ; Tolosa E; Clarimon J; Lleó A; Gelpi E
J Neuropathol Exp Neurol; 2017 Mar; 76(3):216-224. PubMed ID: 28395086
[TBL] [Abstract][Full Text] [Related]
3. Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression.
Sorrentino ZA; Goodwin MS; Riffe CJ; Dhillon JS; Xia Y; Gorion KM; Vijayaraghavan N; McFarland KN; Golbe LI; Yachnis AT; Giasson BI
Acta Neuropathol Commun; 2019 Sep; 7(1):142. PubMed ID: 31477175
[TBL] [Abstract][Full Text] [Related]
4. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
Gómez-Tortosa E; Gonzalo I; Newell K; García Yébenes J; Vonsattel P; Hyman BT
Acta Neuropathol; 2002 May; 103(5):495-500. PubMed ID: 11935266
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy.
Uchikado H; Lin WL; DeLucia MW; Dickson DW
J Neuropathol Exp Neurol; 2006 Jul; 65(7):685-97. PubMed ID: 16825955
[TBL] [Abstract][Full Text] [Related]
6. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
Sierra M; Gelpi E; Martí MJ; Compta Y
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of genetic association studies in people with Lewy body dementia.
Sanghvi H; Singh R; Morrin H; Rajkumar AP
Int J Geriatr Psychiatry; 2020 May; 35(5):436-448. PubMed ID: 31898332
[TBL] [Abstract][Full Text] [Related]
8. Multiplication of the alpha-synuclein gene is not a common disease mechanism in Lewy body disease.
Lockhart PJ; Kachergus J; Lincoln S; Hulihan M; Bisceglio G; Thomas N; Dickson D; Farrer MJ
J Mol Neurosci; 2004; 24(3):337-42. PubMed ID: 15655258
[TBL] [Abstract][Full Text] [Related]
9. Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies.
Hatton C; Reeve A; Lax NZ; Blain A; Ng YS; El-Agnaf O; Attems J; Taylor JP; Turnbull D; Erskine D
Acta Neuropathol Commun; 2020 Jul; 8(1):103. PubMed ID: 32646480
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of beta-synuclein in cortical neurons is associated with autophagy attenuation in the brains of dementia with Lewy body patients.
Evans T; Kok WL; Cowan K; Hefford M; Anichtchik O
Brain Res; 2018 Feb; 1681():1-13. PubMed ID: 29278715
[TBL] [Abstract][Full Text] [Related]
11. Expanding the spectrum of neuronal pathology in multiple system atrophy.
Cykowski MD; Coon EA; Powell SZ; Jenkins SM; Benarroch EE; Low PA; Schmeichel AM; Parisi JE
Brain; 2015 Aug; 138(Pt 8):2293-309. PubMed ID: 25981961
[TBL] [Abstract][Full Text] [Related]
12. Quantifying regional α -synuclein, amyloid β, and tau accumulation in lewy body dementia.
Miller RL; Dhavale DD; O'Shea JY; Andruska KM; Liu J; Franklin EE; Buddhala C; Loftin SK; Cirrito JR; Perrin RJ; Cairns NJ; Campbell MC; Perlmutter JS; Kotzbauer PT
Ann Clin Transl Neurol; 2022 Feb; 9(2):106-121. PubMed ID: 35060360
[TBL] [Abstract][Full Text] [Related]
13. Identification of G-protein coupled receptor kinase 2 in paired helical filaments and neurofibrillary tangles.
Takahashi M; Uchikado H; Caprotti D; Weidenheim KM; Dickson DW; Ksiezak-Reding H; Pasinetti GM
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1157-69. PubMed ID: 17146290
[TBL] [Abstract][Full Text] [Related]
14. Neuropathologic analysis of Lewy-related α-synucleinopathy in olfactory mucosa.
Funabe S; Takao M; Saito Y; Hatsuta H; Sugiyama M; Ito S; Kanemaru K; Sawabe M; Arai T; Mochizuki H; Hattori N; Murayama S
Neuropathology; 2013 Feb; 33(1):47-58. PubMed ID: 22672612
[TBL] [Abstract][Full Text] [Related]
15. Effect of topographical distribution of α-synuclein pathology on TDP-43 accumulation in Lewy body disease.
Yokota O; Davidson Y; Arai T; Hasegawa M; Akiyama H; Ishizu H; Terada S; Sikkink S; Pickering-Brown S; Mann DM
Acta Neuropathol; 2010 Dec; 120(6):789-801. PubMed ID: 20669025
[TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein inclusions in Alzheimer and Lewy body diseases.
Mukaetova-Ladinska EB; Hurt J; Jakes R; Xuereb J; Honer WG; Wischik CM
J Neuropathol Exp Neurol; 2000 May; 59(5):408-17. PubMed ID: 10888371
[TBL] [Abstract][Full Text] [Related]
17. α-synuclein phosphorylation and truncation are normal events in the adult human brain.
Muntané G; Ferrer I; Martinez-Vicente M
Neuroscience; 2012 Jan; 200():106-19. PubMed ID: 22079575
[TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein immunohistochemistry of gastrointestinal and biliary surgical specimens for diagnosis of Lewy body disease.
Ito S; Takao M; Hatsuta H; Kanemaru K; Arai T; Saito Y; Fukayama M; Murayama S
Int J Clin Exp Pathol; 2014; 7(4):1714-23. PubMed ID: 24817969
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein pathology in the cranial and spinal nerves in Lewy body disease.
Nakamura K; Mori F; Tanji K; Miki Y; Toyoshima Y; Kakita A; Takahashi H; Yamada M; Wakabayashi K
Neuropathology; 2016 Jun; 36(3):262-9. PubMed ID: 26563477
[TBL] [Abstract][Full Text] [Related]
20. The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies.
Beyer K; Domingo-Sàbat M; Santos C; Tolosa E; Ferrer I; Ariza A
Brain; 2010 Dec; 133(Pt 12):3724-33. PubMed ID: 20959308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
